About: LTR Pharma Limited, a clinical-stage pharmaceutical company, engages in the research and development of intranasal spray for the treatment erectile dysfunction (ED) in Australia. Its lead product candidate is SPONTAN, an intranasal delivery technology, an oral PDE5 inhibitor and vardenafil HCL for the treatment of ED. The company was incorporated in 2020 and is headquartered in Brisbane, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.47 (-2.08%)
LTP ASX LTR Pharma Ltd
Loading watchlist status…
LTR Pharma Ltd share price
LTP price activity
Last Price
$0.470
Change (24hr)
-0.01 AUD (-2.08%)
Volume
117.52K
Volume (4w avg)
-
Open
$0.49
Day Range
$0.47 - $0.49
Previous Close
$0.48
Last Trade
30 Sep, 5:32 am GMT+0
Delayed
30 Sep, 5:32 am GMT+0
LTP price performance
6.82%
5D
0%
1M
-34.72%
YTD
-25.98%
1Y
Delayed
30 Sep, 5:32 am GMT+0
LTP Market Signals